Cambridge Enterprise Ventures
University of Cambridge's in-house venture arm, investing early-stage capital exclusively in Cambridge academic spin-outs across all disciplines.
Cambridge Innovation Capital
Leading VC backing world-leading deep tech and life sciences spinouts
Canaan Partners
Early-stage VC investing in visionaries with transformative ideas in tech & healthcare
Cannage Capital
Early-stage fund investing across the AI stack from semiconductors to software infrastructure to applications. Led by former operator Shelley Zhuang.
Cantos
San Francisco pre-seed and seed VC backing deeply technical founders in climate tech, computational biology, aerospace, and next-gen computing from day one.
Cape Fear BioCapital
Early-stage VC backing pre-seed and seed therapeutics companies from North Carolina's academic research ecosystem; targets IND-stage milestones
Capita3
Early-stage VC in Minneapolis backing women-led startups in digital health and deep tech, from pre-seed through Series A, with a leadership development platform.
Capital Factory
Austin-based venture firm and Texas's most active early-stage investor since 2010, backing deep and frontier-tech founders others think too early.
Carma Fund
European venture fund backing startups fighting climate change
Cartography Capital
Early-stage fund backing founders building breakthrough technologies and materials for AI chips, quantum computing, robotics, batteries, biotech, and space.
Casdin Capital
New York life-sciences crossover fund moving fluidly between private and public biotech, from gene therapy to diagnostics and data platforms.
CASSTAR
Xi'an-based early-stage venture capital firm backed by the Chinese Academy of Sciences, investing in hard-tech photonics, AI, and aerospace.
Catalio Capital Management
Full lifecycle investments in breakthrough biomedical technology companies
Cathay Venture
Evergreen VC arm of Cathay Financial Holding, Taiwan's largest financial group, backing seed-to-pre-IPO deals in frontier tech, biotech and fintech.
CDH Investments
China-focused venture and growth capital arm of CDH Investments, backing technology innovators in healthcare, AI, hard tech, and enterprise solutions from early stage through growth.
CE-Ventures
Global corporate VC investing in climate and tech
Celesta Capital
Deep-tech focused global VC firm backing transformative science-driven innovation
Cerberus Ventures
Cerberus Capital Management's early-stage venture arm, investing from seed to Series B in AI, energy, infrastructure, compute, and biotech.
Chalmers Ventures
Deep tech investor and venture builder affiliated with Chalmers University of Technology; invests pre-seed to growth in university spinouts across the Nordics
Chemistry VC
Three ex-partners from Index, Bessemer, and a16z pooled their reputations for early Plaid, Twitch, and Twilio checks into one $350M fund with no junior staff between investor and founder.
Chengwei Capital
Shanghai-based independent venture capital firm founded in 1999, backing early to growth-stage Chinese companies across diverse sectors.
Chugai Venture Fund
Corporate VC arm of Chugai Pharmaceutical investing $200M in early-stage preclinical life sciences startups in oncology, immunology, CNS, and rare diseases
Civilization Ventures
Runs a PhD-to-founder Fellowship pipeline alongside its $200M health-tech and biology fund, with exits including Rocket Pharma and Omada Health.
Clave Capital
Spanish VC and tech-transfer firm with 20+ years investing in early-stage healthtech, medtech, biotech, and industrial SMEs; €90M+ AUM; flagship Clave Innohealth fund
Showing 121–144 of 709 investors
Get the Complete BioTech Investor Database
709 investors · Stages · Sectors · Locations · CSV + Excel
Get all 709 investors →